July 17, 2013 — Hologic Inc. recently expanded its array of interventional and imaging solutions for breast health with the launch of the world's first 3-D breast biopsy option. This technology was developed for the company's Affirm upright breast biopsy guidance system, which is used in conjunction with the Selenia Dimensions 2-D and 3-D mammography systems.
The Affirm 3-D biopsy procedure is designed for the localization and accurate targeting of regions of interest and is especially important for targeting lesions not always detected in 2-D images or when using other modalities. This new biopsy technique has numerous advantages over traditional stereotactic biopsy procedures, including faster lesion targeting and reduced patient procedure time. In addition, the Affirm system is pre-programmed for use with the company's Eviva and ATEC vacuum-assisted breast biopsy devices, providing easy integration of these products.
In June 2013, Magee-Womens Hospital of UPMC became the first facility in the nation to perform a tomosynthesis biopsy. Dr. Jules Sumkin, D.O., chief of radiology at Magee, performed the Affirm 3-D biopsy procedure using the Eviva device.
For more information: www.hologic.com